Musculoskeletal Cancers Remote Monitoring and Care

Part of paid clinical trials in Cleveland, Ohio.

Sponsor
Case Comprehensive Cancer Center
Study ID
NCT07129226
Status
Recruiting

Conditions

  • Metastatic Bone Disease
  • Osteosarcoma

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Smart Watch — OTHER
    Participants will be asked to wear the smartwatch daily, for at least 12 hours per day during the 12-week study period, with breaks to recharge the watch as needed.

Study Details

This study aims to evaluate how walking stability and the ability to perform daily activities change during cancer treatment, and whether a smartwatch can detect these changes. The goal is to develop proactive, personalized tools that automatically monitor treatment response and predict potential complications. To support future implementation, the study will assess the feasibility of wearing a smartwatch for at least 12 hours per day, using a mobile application, and completing weekly questionnaires among patients with primary osteosarcoma or metastatic bone disease.

Key Dates

Start date
Feb 11, 2026
Status verified
Jun 2026
Primary completion
Aug 31, 2026
Completion
Aug 31, 2026

Study Design

Enrollment
60 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Experimental: Sarcoma patients
  • Experimental: Palliative radiation for metastatic bone disease patients
  • Experimental: prophylactic surgery for metastatic bone disease patients

Primary Outcome Measure

Adherence Rate post surgery in patients with sarcoma of the lower extremity or pelvis [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Case Comprehensive Cancer Center, Cleveland Clinic FoundationClevelandOhio44195
Zachary Burke, MD
216-445-9174
Rowan Barker-Clarke, Post-Doc Fellow (SUB_INVESTIGATOR)

Find similar trials in Cleveland, OH

Related Studies